Senate lawmakers introduce a bill to help FDA and patent office coordinate

Amid issues that patent reviewers disregard aggressive results on pharmaceuticals, a bipartisan group of senators launched a bill to require the Meals and Drug Administration and the Patent & Trademark Workplace to create a activity pressure to spice up coordination.

The aim is for the businesses to share details about their respective assessment procedures, enhance communication about scientific traits, make it attainable to swap confidential info, and decide whether or not pharmaceutical firms are offering correct representations about their merchandise.